PX
70
2
KMI
63
8
HAS
63
3
WBA
37
5
AA
34
6
FRT
55
2
GS
72
2
HBI
52
6
HBAN
80
3
STZ
38
3
PHM
52
5
TGNA
62
6
HSIC
50
2
XRX
42
11
QCOM
62
13
EA
54
5
PSX
44
9
AME
59
3
REGN
37
2
EMN
48
5
PX
70
2
KMI
63
8
HAS
63
3
WBA
37
5
AA
34
6
FRT
55
2
GS
72
2
HBI
52
6
HBAN
80
3
STZ
38
3
PHM
52
5
TGNA
62
6
HSIC
50
2
XRX
42
11
QCOM
62
13
EA
54
5
PSX
44
9
AME
59
3
REGN
37
2
EMN
48
5
Financhill
Back

Accelerate Diagnostics 10K Form

Sell
20

AXDX
Accelerate Diagnostics

Last Price:
$0.53
Seasonality Move:
32.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AXDX News And Ratings

See the #1 stock for the next 7 days that we like better than AXDX

AXDX Financial Statistics

Sales & Book Value

Annual Sales: $11.7M
Cash Flow: $-5.1M
Price / Cash Flow: 0
Annual Sales: $-2.24
Price / Book: 0

Profitability

EPS (TTM): -2.20000
Net Income (TTM): $-50M
Gross Margin: $2.7M
Return on Equity: 0%
Return on Assets: -171.6%

Accelerate Diagnostics Earnings Forecast

Key Accelerate Diagnostics Financial Ratios

  • The Gross Profit Margin over the past 29 years for AXDX is 23.12%.
  • The Selling, General & Administrative Expenses for AXDX have been equal to 182.30% of Gross Profit Margin.
  • The Research & Development expenses have been 142.66% of Revenue.
  • The Net Earning history of AXDX is -427.81% of Total Revenues.
  • Per Share Earnings over the last 29 years have been positive in 14 years.

Accelerate Diagnostics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: AXDX
CUSIP: 00430H
Website: acceleratediagnostics.com

Debt

Debt-to-Equity Ratio: -1.13
Current Ratio: 0.71
Quick Ratio: 0.59

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AXDX Technical Analysis vs Fundamental Analysis

Sell
20
Accelerate Diagnostics (AXDX) is a Sell

Is Accelerate Diagnostics a Buy or a Sell?